Calunsag, Primitiva B.

HRN: 12-35-20  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/22/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/22/2022
08/28/2022
IVT
4.5g
Q6
Cap Mr
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: No  Wrong Choice  Follow NAG Recommended Antibiotic

Final appropriateness: No  Wrong Choice  Wrong Choice

Overall appropriateness: No  Wrong Choice

Intervention



Type of Intervention done:

                    

           


Acceptance: